AOscopy Adaptive Optics-enhanced multiphoton microscopy
- Coordinator
- Imagine Optic SA, France
- Runs
- 1 June 2025 to 31 May 2028
- Status
- Running
- EU funding
- €2.4m
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 101214841
What the project is doing
In the project's own words, from its summary on CORDIS.
AOscopy aims to establish, quantify and validate the value offer of next-generation multiphoton microscopy using Adaptive Optics (AO), for several applicative use cases in biology, as a key milestone for future exploitation. When targeting deep imaging of biological tissue with subcellular 3D resolution, multiphoton microscopy is the technique of choice, thanks to a unique capability to provide fluorescence images with sub-micron 3D resolution even in scattering media.
Due to these features, multiphoton microscopy is widely used in application fields such as e.g. neuroscience, immunology, oncology, dermatology or developmental biology, as a key tool to enable better understanding of both morphological and functional characteristics of biological systems, with a view on improved diagnosis and therapy of multiple diseases. However, it is most of the time severely limited by the intrinsic optical inhomogeneity of biological media, which is responsible for a limitation of imaging depth and sensitivity.
While AO has proven its capability to overcome this limitation, no integrated, robust AO-enhanced multiphoton microscope is currently available, as an answer to the need from biologists to routinely and easily image deeper, with enhanced contrast, and reduced phototoxicity. AOscopy will: 1. Develop a prototype of an AO-2-photon microscope, based on our recent innovations, enabling to achieve strong signal enhancement (typ. x5), at large depths in biological media (typ. ≥700µm in the mouse brain), while reducing phototoxicity; 2.
Perform market/applicative tests, through the use of the prototype by representative end-users, in order to precise, quantify and validate its value offer in intended environement, for several application fields; 3.Create, structure and develop a start-up company 100% dedicated to AO-based microscopy, in order to accelerate its exploitation and adoption.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Imagine Optic SA | Orsay | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI